EFORT CONGRESS LISBON 2022 | EXHIBITORS & SPONSORS LIST

Nested Applications

LIS22 Past EFORT Congress Exhibitions

PAST EFORT CONGRESS EXHIBITIONS

EFORT understands that in order to assess the relevance of your company exhibiting during 23rd EFORT Congress Lisbon 2022 – it is often useful to see which companies have exhibited at previous EFORT congresses. For your convenience, therefore, please find the complete exhibitor listings for the following annual congresses via the links below:

For any enquiries relating to exhibition, satellites and sponsorship – please contact by using the official exhibitors and sponsorship contact us online form.

Note* : The global Covid-19 pandemic forced EFORT to take the difficult decision to postpone the 21st and 22nd EFORT Annual Congresses that was formerly planned to be held in Vienna, Austria in June 2020 and June-July 2021 respectively.

Exhibitors Database 2022

EXHIBITORS AND PARTNERS LISTING 2022

EFORT invites you to browse through the Exhibitors Database of the 23rd EFORT Annual Congress Lisbon 2022 which represents those exhibitors that have already committed to and confirmed their presence at the 2022 EFORT Congress to be held in Lisbon, Portugal from 22 to 24 June 2022.

EFORT Industry Database


Aptissen S.A.

Chemin du champ des filles 36 A
1228 Plan-Les-Ouates (GE)
Switzerland
Phone: +41 22 552 2106
About Us

Aptissen S.A. is a Swiss company specialized in the development and commercialization of biopolymer-based medical devices. Aptissen’s founders have developed for the past 25 years the best quality injectable products which meet both patients and doctors expectations: www.aptissen.com

The company was founded in 2013 as a spin-off of ANTEIS, and is based in Geneva area, Switzerland. It today distributes its products through a worldwide international distributors' network among more than 90 countries including Europe, South America, Canada, Middle East and Asia.

Aptissen's team revolutionized the viscosupplement market with Synolis VA and his patented formulation which combines Hyaluronic Acid and Sorbitol. Synolis VA provides rapid mobility recovery, fast long lasting pain relief associated with excellent safety: www.synolis.com

We place the patient benefit at the center of our mission to develop innovative injectable solutions based on hyaluronic acid to provide fast pain relief.

Area of Business: Biotechnology
Category: Osteoarthritis, Orthopaedic, Rheumatology, Joint pain, Viscosupplement, Hyaluronic Acid y Injectable
Number of Employees worldwide: 11 to 50 employees
Founded in: 2013
Products
Cartylis
Cartylis is a drinkable food supplement providing a boost for joints.
Category: Food Supplement
Synolis VA
SYNOLIS VA reduces local pain and discomfort caused by symptomatic OA and improves mobility of the synovial joints of the knee and hip (for hip, SYNOLIS VA 80/160 only). Because all patients are different, we have developed the Synolis VA range, which can be used as a single or multi-injection to relieve patients from pain and improve their mobility.
Category: Viscosupplements
Please contact us by e-Mail to request a meeting.